Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chau T Dang

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
JACC. Cardiovascular Imaging|August 11, 2018
Left Ventricular Ejection Fraction Monitoring Adherence Rates: Why So Low?Chau T Dang, Anne Blaes, Filipa Lynce, et al.
The Oncologist|August 19, 2018
In ReplyChau T Dang, Jasmeet C Singh, Richard M Steingart, et al.
Annals of Surgical Oncology|July 24, 2022
Neoadjuvant Chemotherapy for Breast Cancer In the Elderly: Are We Accomplishing Our Treatment Goals?Austin D Williams, Chau T Dang, Varadan Sevilimedu, et al.
Breast Cancer Research and Treatment|February 6, 2019
Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fractionYasin Hussain, Esther Drill, Chau T Dang, et al.
Therapeutic Advances in Medical Oncology|August 14, 2023
Evolving perspectives on the treatment of HR+/HER2+ metastatic breast cancerMark Pegram, Richard Pietras, Chau T Dang, et al.
JAMA Oncology|July 29, 2018
Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialJoseph Sparano, Anne O'Neill, Katherine Alpaugh, et al.
JAMA Oncology|October 15, 2020
Early Trastuzumab Interruption and Recurrence-Free Survival in ERBB2-Positive Breast CancerRobert S Copeland-Halperin, Mohammed Al-Sadawi, Sujata Patil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2016
Cardiac Surveillance Guidelines for Trastuzumab-Containing Therapy in Early-Stage Breast Cancer: Getting to the Heart of the MatterChau T Dang, Anthony F Yu, Lee W Jones, et al.
NPJ Breast Cancer|February 9, 2022
Inflammatory cytokines and distant recurrence in HER2-negative early breast cancerJoseph A Sparano, Anne O'Neill, Noah Graham, et al.
JCO Oncology Practice|May 11, 2023
Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Comparative Effectiveness Study Using US Electronic Health RecordsLetizia Polito, Jinjoo Shim, Sara A Hurvitz, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
JACC. Cardiovascular Imaging|August 11, 2018
Left Ventricular Ejection Fraction Monitoring Adherence Rates: Why So Low?Chau T Dang, Anne Blaes, Filipa Lynce, et al.
The Oncologist|August 19, 2018
In ReplyChau T Dang, Jasmeet C Singh, Richard M Steingart, et al.
Annals of Surgical Oncology|July 24, 2022
Neoadjuvant Chemotherapy for Breast Cancer In the Elderly: Are We Accomplishing Our Treatment Goals?Austin D Williams, Chau T Dang, Varadan Sevilimedu, et al.
Breast Cancer Research and Treatment|February 6, 2019
Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fractionYasin Hussain, Esther Drill, Chau T Dang, et al.
Therapeutic Advances in Medical Oncology|August 14, 2023
Evolving perspectives on the treatment of HR+/HER2+ metastatic breast cancerMark Pegram, Richard Pietras, Chau T Dang, et al.
JAMA Oncology|July 29, 2018
Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialJoseph Sparano, Anne O'Neill, Katherine Alpaugh, et al.
JAMA Oncology|October 15, 2020
Early Trastuzumab Interruption and Recurrence-Free Survival in ERBB2-Positive Breast CancerRobert S Copeland-Halperin, Mohammed Al-Sadawi, Sujata Patil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2016
Cardiac Surveillance Guidelines for Trastuzumab-Containing Therapy in Early-Stage Breast Cancer: Getting to the Heart of the MatterChau T Dang, Anthony F Yu, Lee W Jones, et al.
NPJ Breast Cancer|February 9, 2022
Inflammatory cytokines and distant recurrence in HER2-negative early breast cancerJoseph A Sparano, Anne O'Neill, Noah Graham, et al.
JCO Oncology Practice|May 11, 2023
Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Comparative Effectiveness Study Using US Electronic Health RecordsLetizia Polito, Jinjoo Shim, Sara A Hurvitz, et al.
Pageof 8